Onderzoeker
Lana Langendries
- Disciplines:Infectieziekten, Virologie
Affiliaties
- Laboratorium Virologie en Chemotherapie (Rega Instituut) (Afdeling)
Lid
Vanaf27 aug 2018 → Heden
Projecten
1 - 1 of 1
- Klassieke en nieuwe strategieën tegen arbovirussen: effect van antivirale geneesmiddelen en huidbacteriën op virus infectiviteitVanaf27 aug 2018 → 4 okt 2022Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 8 van 8
- Classic and new strategies to fight arboviruses: effect of antiviral drugs and skin bacteria on virus infectivity(2022)
Auteurs: Lana Langendries, Leen Delang, Johan Neyts
- Perturbation of Alphavirus and Flavivirus Infectivity by Components of the Bacterial Cell Wall(2022)
Auteurs: Lana Langendries, Rana Abdelnabi, Sam Verwimp, Suzanne Kaptein, Leen Delang
- An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models(2021)
Auteurs: Lana Langendries, Sofie Jacobs, Sebastiaan ter Horst, Laura Seldeslachts, Laurens Liesenborghs, Robbert Boudewijns, Hendrik Jan Thibaut, Kai Dallmeier, Greetje Vande Velde, Birgit Weynand, et al.
- The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model(2021)
Auteurs: Rana Abdelnabi, Suzanne Kaptein, Lana Langendries, Laura Vangeel, Valentijn Vergote, Elisabeth Heylen, Pieter Leyssen, Kai Dallmeier, Lotte Coelmont, Patrick Augustijns, et al.
- itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens (vol 66, 103288, 2021)(2021)
Auteurs: Laurens Liesenborghs, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Sebastiaan ter Horst, Erwin Dreesen, Tatjana Geukens, Ewout Landeloos, Bert Vandenberk, Lorenz Van der Linden, et al.
- Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors(2021)
Auteurs: Lana Langendries, Rana Abdelnabi, Johan Neyts, Leen Delang
- Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial(2021)
Auteurs: Laurens Liesenborghs, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Laure-Anne Teuwen, Sebastiaan ter Horst, Erwin Dreesen, Tatjana Geukens, Ewout Landeloos, Vincent Geldhof, et al.
- Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity(2020)
Auteurs: Suzanne Kaptein, Sofie Jacobs, Lana Langendries, Laura Seldeslachts, Sebastiaan ter Horst, Laurens Liesenborghs, Bart Hens, Valentijn Vergote, Elisabeth Heylen, Rana Abdelnabi, et al.
Pagina's: 26955 - 26965